ProPhase Labs (PRPH)
Add to Watchlists Create an AlertPRPH Key Stats
| Income Statement | |
| Revenue TTM | 22.40M |
| Revenue Quarterly YoY Growth | 21.67% |
| EPS Diluted TTM | -0.0798 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -1.092M |
| Profitability | |
| Gross Profit Margin Quarterly | 62.65% |
| Profit Margin Quarterly | 4.98% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 25.19M |
| Enterprise Value | 24.46M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 2.200 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | -2.313M |
| Return on Equity | -10.51% |
PRPH News
- PROPHASE LABS, INC. Files SEC form 8-K/A, Submission of Matters to a Vote of Sec... May 21
- PROPHASE LABS, INC. Files SEC form 10-Q, Quarterly Report May 10
- PROPHASE LABS, INC. Files SEC form 8-K, Change in Directors or Principal Officer... May 9
- PROPHASE LABS, INC. Files SEC form 8-K, Results of Operations and Financial Cond... May 7
- ProPhase Labs Reports Financial Results for the First Quarter Ended March 31, 20... May 6
- PROPHASE LABS, INC. Financials Apr 3
- PROPHASE LABS, INC. Files SEC form 10-K, Annual Report Mar 28
- ProPhase Labs Reports Financial Results for the Fourth Quarter and Year Ended De... Mar 26
- PROPHASE LABS, INC. Files SEC form 8-K, Results of Operations and Financial Cond... Mar 26
- Prophase Labs (PRPH) Swings to Q4 Profit Street Insider Mar 26
PRPH Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). ProPhase Labs is up 52.88% over the last year vs S&P 500 Total Return up 27.81%, GlaxoSmithKline up 26.92%, and Tetraphase Pharmaceuticals down 0.26%.
PRPH Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these PRPH related companies
Pro Ratings for PRPH
Pro Report PDF for PRPH
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download PRPH Pro Report PDF
Pro Strategies Featuring PRPH
Did ProPhase Labs make it into our Pro Portfolio Strategies?
PRPH Profile
Sector: Healthcare
Industry: Drug Manufacturers - Major
Other PRPH Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PRPH | 1.59 | +0.01 | +0.63% | 25.19M |
